- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07635576
Effect of Gastric Electrical Stimulation on Serum Insulin Levels
Defining the Effect of Gastric Electrical Stimulation on Serum Insulin Levels in Human Subjects
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Up to thirty-two adult patients with gastroparesis who have undergone implantation of a gastric stimulation device at least three months prior are candidates for study. Diabetic patients who are taking exogenous insulin are excluded from study The study consists of two groups, an EXPERIMENTAL group that undergoes turning off the GES and a CONTROL group that does not undergo the turning off of the GES. The subjects are randomized to either the control or experimental group. The study Coordinator will create a block randomization schedule in Excel (Block Randomization in Clinical Trials: Video Tutorial in Microsoft Excel)(10). The study Coordinator will use the Excel randomization schedule to assign the treatment and will administer the stimulus accordingly. No one will be blinded to any of the arms of the study.
After an overnight fast, the patients are placed in the supine position on a hospital bed, and an intravenous line is inserted and capped. The study consists of three separate and consecutive periods: 1. Baseline, a 20-minute period during which GES is left ON at each patient's pre-study settings; 2. Experimental, a 4-hour period during which the GES device is turned OFF; 3. Recovery, a 20-minute period during which GES is turned back ON to the patient's pre-study settings. A 5-ml sample of blood will be removed from each patient after placement of the flexible IV catheter secured with tape, the Baseline, and Recovery study periods. During the Experimental period a blood sample is withdrawn after 30 minutes and then again at the 1-hour, 2-hour, 3-hour and 4-hour intervals through a flexible IV catheter secured with tape , with the possibility of up to 8 blood draws over the duration of the study.
Plasma samples are analyzed for glucose, C-peptide, GLP-1 and insulin levels. The analysis of variance is used to determine whether there is any significant effect of time on the resultant values. In a previous study we examined the variance of patient demographics (age, gender, and BMI). As patients with implanted electrical stimulators typically have different stimulator settings to control their symptoms, this arm of the study examines whether stimulation parameters such as pulse duration, amplitude or frequency have any effect on individual response to gastric electrical stimulation. A correlation coefficient analysis is used to determine if any variable shows a significant effect.
During the study EKG electrodes are placed over the extremities and precordium and recordings continued during the respective Baseline, Experimental, and Recovery periods. EKG signals are digitized and downloaded to a computer for time domain power spectral analysis of heart rate variability using commercially available software. This analysis will determine the influence of sympathetic and parasympathetic mechanisms during the respective time periods.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Thomas V Nowak, MD
- Telefonnummer: 3179484272
- E-Mail: tvnowak@iu.edu
Studieren Sie die Kontaktsicherung
- Name: Maureen V Schilling, BA
- Telefonnummer: 3172782064
- E-Mail: maschi@iu.edu
Studienorte
-
-
Indiana
-
Indianapolis, Indiana, Vereinigte Staaten, 46202
- Rekrutierung
- Indiana University Hospital
-
Kontakt:
- Thomas V Nowak, MD
- Telefonnummer: 3179484272
- E-Mail: tvnowak@iu.edu
-
Kontakt:
- Maureen Schilling, BA
- Telefonnummer: 317-278-2064
- E-Mail: maschi@iu.edu
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
• At least 18 years of age.
- Documented diagnosis of gastroparesis
- Not taking diabetic prescribed exogenous insulin.
- Patient has a GES device that has been implanted for at least 3 months.
- Willing to give up to 8 blood samples.
- Willing to lie in a bed for up to 5.5 hours.
Exclusion Criteria:
• Pregnancy
- History of allergic reaction to EKG lead placement adhesives.
- Unable to give informed consent.
- Unwilling to give up to 8 5 ml blood samples.
- Unwilling to lie in a bed for up to 5.5 hours.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Zufällig
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: The OFF Group
This group of subjects will have their GES interrogated and observed as well as having the device turned off for the duration of the experiment.
The device will then be re-interrogated and turned back on at the end of the experiment.
|
Device will either be turned off for the duration of the experiment, or the device will be left on for the duration of the experiment
Andere Namen:
|
|
Schein-Komparator: SHAM Group
This group of subjects will have their GES interrogated and observed yet will not have the device turned off for the duration of the experiment.
The device will then be re-interrogated at the end of the experiment.
This is to retain the illusion of the device being turned back on.
|
Device will either be turned off for the duration of the experiment, or the device will be left on for the duration of the experiment
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Definition of Effect
Zeitfenster: Up to four hours depending on the subject's preference/tolerability.
|
To define the effect of prolonged four-hour withdrawal of gastric electrical stimulation on serum insulin and C-peptide levels in human subjects.
Insulin and C-peptide are co-primary end points.
|
Up to four hours depending on the subject's preference/tolerability.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Comparing Hormone Levels
Zeitfenster: Up to four hours depending on the subject's preference/tolerability.
|
To compare the changes in serum insulin and C-peptide levels after 4-hour withdrawal of gastric electrical stimulation to a control group that does not undergo withdrawal of gastric electrical stimulation.
|
Up to four hours depending on the subject's preference/tolerability.
|
|
Definition of 4-Hour Withdrawl of GES Device
Zeitfenster: Up to four hours depending on the subject's preference/tolerability.
|
To define the effect of prolonged four-hour withdrawal of gastric electrical stimulation on serum GLP-1 and glucose levels in human subjects.
GLP-1 and glucose are co-secondary end points.
|
Up to four hours depending on the subject's preference/tolerability.
|
|
Changes in Glucose and GLP-1 Levels
Zeitfenster: Up to four hours depending on the subject's preference/tolerability.
|
To compare the changes in serum GLP-1 and glucose levels after 4-hour withdrawal of gastric electrical stimulation to a control group that does not undergo withdrawal of gastric electrical stimulation.
|
Up to four hours depending on the subject's preference/tolerability.
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Tertiary Objective
Zeitfenster: Up to four hours depending on the subject's preference/tolerability.
|
To determine whether changes noted in serum levels of insulin, C-peptide, GLP-1 and glucose are associated with alterations in heart rate variability and sympathetic and parasympathetic autonomic activation.
|
Up to four hours depending on the subject's preference/tolerability.
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Thomas V Nowak, MD, IU School of Medicine/IU Health
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- van der Voort IR, Becker JC, Dietl KH, Konturek JW, Domschke W, Pohle T. Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis. Exp Clin Endocrinol Diabetes. 2005 Jan;113(1):38-42. doi: 10.1055/s-2004-830525.
- Vosseler A, Zhao D, Fritsche L, Lehmann R, Kantartzis K, Small DM, Peter A, Haring HU, Birkenfeld AL, Fritsche A, Wagner R, Preissl H, Kullmann S, Heni M. No modulation of postprandial metabolism by transcutaneous auricular vagus nerve stimulation: a cross-over study in 15 healthy men. Sci Rep. 2020 Nov 24;10(1):20466. doi: 10.1038/s41598-020-77430-2.
- Kozorosky EM, Lee CH, Lee JG, Nunez Martinez V, Padayachee LE, Stauss HM. Transcutaneous auricular vagus nerve stimulation augments postprandial inhibition of ghrelin. Physiol Rep. 2022 Apr;10(8):e15253. doi: 10.14814/phy2.15253.
- Payne SC, Ward G, Fallon JB, Hyakumura T, Prins JB, Andrikopoulos S, MacIsaac RJ, Villalobos J. Blood glucose modulation and safety of efferent vagus nerve stimulation in a type 2 diabetic rat model. Physiol Rep. 2022 Apr;10(8):e15257. doi: 10.14814/phy2.15257.
- Hampton RF, Jimenez-Gonzalez M, Stanley SA. Unravelling innervation of pancreatic islets. Diabetologia. 2022 Jul;65(7):1069-1084. doi: 10.1007/s00125-022-05691-9. Epub 2022 Mar 29.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 30020 (DAIDS-ES Registry Number)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Gastroparese Nichtdiabetiker
-
The Cleveland ClinicAktiv, nicht rekrutierendGastroparesis-ähnliche SymptomeVereinigte Staaten
Klinische Studien zur Gastric Electrical Stimulator
-
Texas Tech University Health Sciences Center, El...AbgeschlossenGastropareseVereinigte Staaten
-
Leidos Life SciencesAbgeschlossen
-
Chinese University of Hong KongRekrutierung
-
Wonkwang University HospitalAbgeschlossenGastroparese | Magenentleerung | Präoperative BetreuungSüdkorea
-
Institut National de la Santé Et de la Recherche...AbgeschlossenAlzheimer ErkrankungFrankreich
-
Universitaire Ziekenhuizen KU LeuvenBeendet
-
Chinese University of Hong KongRekrutierung
-
Chinese University of Hong KongRekrutierung
-
University of OklahomaZurückgezogenEntzündung | STEMI - Myokardinfarkt mit ST-HebungVereinigte Staaten
-
University of ManchesterRekrutierungNachwirkungen von PES, die mit RTMs auf dem menschlichen Pharyngealmotorkortex vorkonditioniert sindGesunde Probanden (HS)Vereinigtes Königreich